Yes, you can now check your prostate cancer surgeon’s complication rates, but …

… You are going to need to be cautious in using this new tool, as explained below. … READ MORE …

Fallout from elimination of PSA data from the SEER database

On April 29 this year, the National Cancer Institute (NCI) announced a decision to eliminate all PSA data from their current data files because of apparent inaccuracies in the ways that such data had been accumulated over time and administered. The full ramifications of this are — as yet — unclear. … READ MORE …

Congress may block coverage for VEDs for Medicare patients

It appears as though, here in the USA, the House of Representatives has decided to block coverage of vacuum erectile devices (VEDs, sometimes known as “penis pumps”) for Medicare patients. … READ MORE …

“Best care” doesn’t equate to better outcomes! That’s not good!

A poster by Schroeck et al. — to be presented on May 20 at the upcoming annual meeting of the American Urological Association (AUA) — presents the latest set of data suggesting that “best care” does not lead to appropriate outcomes quality for men receiving standard forms of treatment for localized prostate cancer. … READ MORE …

Cost and prevalence of PSA testing in Medicare patients > 70 years old

A recent article in Cancer has stimulated media coverage of the appropriate role of PSA testing in men of > 70 years of age and costs covered by Medicare for PSA tests in men over this age. … READ MORE …

The over-treatment of low-risk disease in the Medicare community

So there’s a lot of media coverage this morning about an article in the Journal of the American Medical Association suggesting that, here in the USA, more men with low-risk forms of localized prostate cancer are getting more expensive types of treatment for their cancer (and that much of this treatment may be of dubious value). … READ MORE …

VHA cancer management quality study does NOT include prostate cancer

A new study in the Journal of Clinical Oncology has provided data regarding the survival of men of 65 years and older diagnosed with and treated for selected cancers within the Veterans Health Administration (VHA) system as compared to similar men treated under the fee-for-service Medicare system. This study has received a lot of media coverage. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,351 other followers